Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

FOXN1 gene variants cause low T cells and immune issues from birth.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Permanent hair dye may cause total hair loss.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

CBD can either promote or inhibit hair growth depending on the concentration used.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Leflunomide is more likely to help treat alopecia areata than cause it.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.